Detroit tops survey of cities that need the most initial COVID-19 vaccines
A recent survey of cities that need the most initial vaccinations against COVID-19 ranked Detroit number one.
Its ranking came from a study by the financial website WalletHub.com, which compared 90 large cities across 13 key metrics related to health.
Most Vaccinations
1. Detroit, MI
2. Cleveland, Ohio
3. Birmingham, AL
4. Memphis, TN
5. Louisville, KY
6. Toledo, Ohio
7. Baton Rouge, LA
8. Buffalo, NY
9. Cincinnati, Ohio
10. Newark, NJ
Least Vaccinations
1. Austin, Texas
2. Chandler, AZ
3. San Diego, CA
4. Denver, CO
5. Gilbert, AZ
6. Seattle, WA
7. San Jose, CA
8. San Francisco, CA
9. Fremont, CA
10. Irvine, CA
The data set ranged from each city’s share of frontline health care workers and nursing home residents to number of essential workers and residents diagnosed with various diseases. In many cases, Detroit ranked in the top five in terms of highest share of population suffering from diseases that put its population at risk.
Each metric was scored on a 100-point scale, with 100 representing the highest share of people in need of vaccinations. Each state’s weighted average across all metrics was then used to determine an overall score and the rank-order for states shown here:
Highest share of adult population diagnosed with chronic kidney disease:
1. Detroit, MI
2. Cleveland, Ohio
3. Newark, NJ
4. Birmingham, AL
5. Hialeah, FL
6. San Bernardino, CA Lowest share of adult population diagnosed with chronic kidney disease:
1. San Francisco, CA
2. Seattle, WA
3. Plano, Texas
4. Scottsdale, AZ
5. Irvine, CA
6. Fremont, CA
Highest share of adult population diagnosed with cardiovascular disease:
1. Cleveland, Ohio
2. Detroit, MI
3. Louisville, KY
4. Cincinnati, Ohio Lowest share of adult population diagnosed with cardiovascular disease:
1. San Jose, CA
2. San Francisco, CA
3. Seattle, WA
4. Irvine, CA
5. Freemont, CA
Highest share of adult population diagnosed with diabetes:
1. Detroit, MI
2. Cleveland, Ohio
3. Louisville, KY
4. Toledo, Ohio
5. Memphis, TN
Lowest share of adult population diagnosed with diabetes:
1. Colorado Springs, CO
2. Chandler, AZ
3. Madison, WI
4. Gilbert, AZ
5. Scottsdale, AZ Highest share of adult population with chronic obstructive pulmonary disease:
1. Detroit, MI
2. Cleveland, Ohio
3. Louisville, KY
4. Toledo, Ohio
5. Memphis, TN
Lowest share of adult population with chronic obstructive pulmonary disease:
1. San Jose, CA
2. Honolulu, Hawaii
3. San Francisco, CA
4. Seattle, WA
5. Irvine, CA
6. Freemont, CA
Highest share of adult population diagnosed with asthma:
1. Detroit, MI
2. Buffalo, NY
3. Memphis, TN
4. Cleveland, Ohio
5. Philadelphia, PA Lowest share of adult population diagnosed with asthma:
1. San Francisco, CA
2. Plano, Texas
3. Hialeah, FL
4. Irvine, CA
5. Freemont, CA
Highest share of adult population diagnosed with hypertension:
1. Detroit, MI
2. Birmingham, AL
3. Baton Rouge, LA
4. Memphis, TN
5. New Orleans, LA Lowest share of adult population diagnosed with hypertension:
1. Gilbert, AZ
2. Irvine, CA
3. Scottsdale, AZ
4. Seattle, WA
5. Freemont, CA
Highest share of obese adult population:
1. Detroit, MI
2. Cleveland, Ohio
3. Baton Rouge, LA
4. Birmingham, AL
5. Toledo, Ohio
Lowest share of obese adult population:
1. Denver, CO
2. San Jose, CA
3. Fremont, CA
4. Irvine, CA
5. San Francisco, CA In determining the sample, WalletHub considered only the city proper in each case, excluding cities in the surrounding metro area. Data was collected from the United States Census Bureau.
A United States government advisory panel will decide whether to endorse mass use of Pfizer’s COVID-19 vaccine to help conquer the outbreak that has killed close to 300,000 Americans. The final approval is expected to come Thursday.
The meeting of outside advisers to the Food and Drug Administration represents the next-to-last hurdle before the expected start of the biggest vaccination campaign in U.S. history. Depending on how fast the FDA signs off on the panel’s recommendation, shots could begin within days.
“The American public demands and deserves a rigorous, comprehensive and independent review of the data,” said the FDA’s Dr. Doran Fink, who described agency scientists working nights, weekends and over Thanksgiving to get that done.